A trial of calcitonin therapy in renal osteodystrophy.
作者信息
Delano B G, Baker R, Gardner B, Wallach S
出版信息
Nephron. 1973;11(5):287-93. doi: 10.1159/000180236.
PMID:4753519
Abstract
摘要
相似文献
1
A trial of calcitonin therapy in renal osteodystrophy.
Nephron. 1973;11(5):287-93. doi: 10.1159/000180236.
2
3
Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
J Urol Nephrol (Paris). 1976 Apr-May;82(4-5):359-62.
4
Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154.
5
Osteodystrophy of dialysed patients treated with vitamin D.
Proc Eur Dial Transplant Assoc. 1973;10(0):217-26.
6
[Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
Minerva Med. 1985 Mar 10;76(9-10):419-23.
7
1alpha-Hydroxycholecalciferol in renal osteodystrophy.
Calcif Tissue Res. 1977 May;22 Suppl:105-11. doi: 10.1007/BF02064049.
8
A possible role for propranolol in the treatment of renal osteodystrophy.
Lancet. 1978 Aug 26;2(8087):451-4. doi: 10.1016/s0140-6736(78)91447-2.
9
[Subtotal parathyroidectomy in the treatment of renal osteodystrophy in 8 patients under chronic hemodialysis].
Rev Med Chil. 1984 Jun;112(6):564-9.
10
Fluoride and dialysis osteodystrophy: results of a double-blind study.
Trans Am Soc Artif Intern Organs. 1974;20A:203-8.
引用本文的文献
1
Calcitonin, the forgotten hormone: does it deserve to be forgotten?
Clin Kidney J. 2015 Apr;8(2):180-7. doi: 10.1093/ckj/sfv011. Epub 2015 Mar 20.
Zotero 插件